James Hoyes, previously chief commercial officer for EMD Serono Inc, has been appointed president with responsibility for driving the strategic direction of the US affiliate of Merck KGaA.
In his new role, he will also be a member of the executive management board of Merck Serono, the global pharmaceuticals division of Merck KGaA. Mr Hoyes previously worked at Elan Corporation Plc and at Sanofi SA.
Copyright 2011 Evernow Publishing Ltd